Furthermore, they found T cell proliferation was restored and Vκ*MYC tumor progression was significantly delayed when they knocked out ARG1 in MM-bearing mice or applied ARG inhibitors (95). The gene discussed is MYC; the disease is Miyoshi myopathy.